Smith & Nephew (SNN) Completes Gynaecology Business Divestiture; Commences Stock Buyback Plan

August 8, 2016 6:16 AM EDT
Get Alerts SNN Hot Sheet
Trade SNN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Smith & Nephew (NYSE: SNN) announces that it has completed the divestiture of its Gynaecology business to Medtronic plc (NYSE: MDT) for $350 million.

The planned sale of our Gynaecology business demonstrates our disciplined strategic approach to capital deployment. Our shareholders will benefit directly through a $300 million share buy-back programme. The divestment is expected to be broadly neutral to adjusted earnings per share ('EPSA') in 2017, after the share buy-back, and to reduce EPSA by less than 1.0ยข in 2016.

The maximum pecuniary amount allocated to the buy-back programme is $300 million and the maximum number of shares that will be purchased is estimated to be 18.3 million1 based on the prevailing share price and GBP/USD exchange rate. The buy-back programme, the purpose of which is to reduce the Company's share capital, commences today and will end no later than 31 March 2017.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Spinoffs, Stock Buybacks

Related Entities

Stock Buyback, Earnings

Add Your Comment